Albert David Limited (ALBERTDAVD.NS)
INR 851.7
(0.7%)
INR 851.7
(0.7%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -278.36 Million INR | -818.85% |
| 2022 | 38.72 Million INR | 14.38% |
| 2021 | 33.85 Million INR | 197.93% |
| 2020 | -34.57 Million INR | 20.88% |
| 2019 | -43.69 Million INR | 31.86% |
| 2018 | -64.12 Million INR | -390.18% |
| 2017 | 22.09 Million INR | -86.49% |
| 2016 | 163.61 Million INR | 415.98% |
| 2015 | 31.71 Million INR | -84.4% |
| 2014 | 203.32 Million INR | -38.09% |
| 2013 | 328.4 Million INR | 41.24% |
| 2012 | 232.52 Million INR | -8.47% |
| 2011 | 254.03 Million INR | 7.94% |
| 2010 | 235.33 Million INR | -41.75% |
| 2009 | 404.02 Million INR | -3.96% |
| 2008 | 420.68 Million INR | -18.87% |
| 2007 | 518.5 Million INR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | - INR | 100.0% |
| 2023 Q1 | 2.03 Billion INR | 5148.26% |
| 2023 Q2 | -38.82 Million INR | -101.91% |
| 2023 Q4 | -278.36 Million INR | -112.49% |
| 2023 FY | -278.36 Million INR | -818.85% |
| 2023 Q3 | 2.22 Billion INR | 5841.05% |
| 2022 Q4 | 38.72 Million INR | -97.9% |
| 2022 Q1 | 1.74 Billion INR | 5063.34% |
| 2022 FY | 38.72 Million INR | 14.38% |
| 2022 Q2 | -23.21 Million INR | -101.33% |
| 2022 Q3 | 1.84 Billion INR | 8043.03% |
| 2021 Q1 | 1.49 Billion INR | 4415.55% |
| 2021 Q2 | -12.83 Million INR | -100.86% |
| 2021 Q4 | 33.85 Million INR | -98.19% |
| 2021 Q3 | 1.87 Billion INR | 14690.92% |
| 2021 FY | 33.85 Million INR | 197.93% |
| 2020 Q2 | -33.23 Million INR | 0.0% |
| 2020 Q4 | -34.57 Million INR | -102.84% |
| 2020 Q3 | 1.21 Billion INR | 3766.38% |
| 2020 FY | -34.57 Million INR | 20.88% |
| 2019 Q2 | -39.24 Million INR | -103.99% |
| 2019 FY | -43.69 Million INR | 31.86% |
| 2019 Q4 | -43.69 Million INR | -104.09% |
| 2019 Q3 | 1.06 Billion INR | 2822.58% |
| 2019 Q1 | 984.04 Million INR | 1634.67% |
| 2018 Q3 | 743.89 Million INR | 5366.13% |
| 2018 Q4 | -64.12 Million INR | -108.62% |
| 2018 FY | -64.12 Million INR | -390.18% |
| 2018 Q1 | 744.03 Million INR | 3267.15% |
| 2018 Q2 | -14.12 Million INR | -101.9% |
| 2017 Q1 | 537.85 Million INR | 228.73% |
| 2017 Q4 | 22.09 Million INR | -95.78% |
| 2017 Q3 | 523.99 Million INR | 713.16% |
| 2017 FY | 22.09 Million INR | -86.49% |
| 2017 Q2 | 64.43 Million INR | -88.02% |
| 2016 Q3 | 572.68 Million INR | 636.68% |
| 2016 FY | 163.61 Million INR | 415.98% |
| 2016 Q1 | 542.11 Million INR | 1609.6% |
| 2016 Q4 | 163.61 Million INR | -71.43% |
| 2016 Q2 | 77.73 Million INR | -85.66% |
| 2015 Q3 | 100.15 Million INR | -10.38% |
| 2015 Q4 | 31.71 Million INR | -68.34% |
| 2015 FY | 31.71 Million INR | -84.4% |
| 2015 Q2 | 111.75 Million INR | 0.0% |
| 2014 Q1 | 92.56 Million INR | -71.81% |
| 2014 Q3 | 97.25 Million INR | -45.48% |
| 2014 Q2 | 178.37 Million INR | 92.69% |
| 2014 FY | 203.32 Million INR | -38.09% |
| 2014 Q4 | 203.32 Million INR | 109.06% |
| 2013 Q2 | 272.55 Million INR | 87.54% |
| 2013 Q4 | 328.4 Million INR | 299.39% |
| 2013 FY | 328.4 Million INR | 41.24% |
| 2013 Q1 | 145.33 Million INR | -37.5% |
| 2013 Q3 | 82.22 Million INR | -69.83% |
| 2012 FY | 232.52 Million INR | -8.47% |
| 2012 Q4 | 232.52 Million INR | 0.0% |
| 2012 Q2 | 215.27 Million INR | 0.0% |
| 2011 FY | 254.03 Million INR | 7.94% |
| 2011 Q4 | 254.03 Million INR | 0.0% |
| 2010 FY | 235.33 Million INR | -41.75% |
| 2009 FY | 404.02 Million INR | -3.96% |
| 2008 FY | 420.68 Million INR | -18.87% |
| 2007 FY | 518.5 Million INR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Hester Biosciences Limited | 2.29 Billion INR | 112.152% |
| Alembic Limited | 66.9 Million INR | 516.097% |
| Alkem Laboratories Limited | -1.6 Billion INR | 82.704% |
| Alembic Pharmaceuticals Limited | 3.86 Billion INR | 107.201% |
| Bafna Pharmaceuticals Limited | 229.93 Million INR | 221.065% |
| Bajaj HealthCare Limited | 3.29 Billion INR | 108.438% |
| FDC Limited | -57.75 Million INR | -382.008% |
| Glenmark Life Sciences Limited | -2.84 Billion INR | 90.207% |
| Gufic Biosciences Limited | 3.19 Billion INR | 108.715% |
| Hikal Limited | 7.96 Billion INR | 103.494% |
| Ind-Swift Laboratories Limited | -4.15 Billion INR | 93.297% |
| Ind-Swift Limited | 9.5 Billion INR | 102.928% |
| Innova Captab Limited | 2.33 Billion INR | 111.928% |
| Jagsonpal Pharmaceuticals Limited | -1.38 Billion INR | 79.972% |
| Jubilant Pharmova Limited | 27.07 Billion INR | 101.028% |
| Kilitch Drugs (India) Limited | 120.03 Million INR | 331.899% |
| Laurus Labs Limited | 24.35 Billion INR | 101.143% |
| Lincoln Pharmaceuticals Limited | -127.63 Million INR | -118.093% |
| Lupin Limited | 19.38 Billion INR | 101.436% |
| Mangalam Drugs & Organics Limited | 975.81 Million INR | 128.527% |
| Medico Remedies Limited | 78.67 Million INR | 453.812% |
| Morepen Laboratories Limited | -231.17 Million INR | -20.415% |
| Nectar Lifesciences Limited | 6.15 Billion INR | 104.521% |
| Orchid Pharma Limited | -1.31 Billion INR | 78.813% |
| Procter & Gamble Health Limited | -2.34 Billion INR | 88.144% |
| RPG Life Sciences Limited | -364.7 Million INR | 23.672% |
| Solara Active Pharma Sciences Limited | 10.03 Billion INR | 102.775% |
| Sun Pharmaceutical Industries Limited | -72.47 Billion INR | 99.616% |
| Suven Pharmaceuticals Limited | 144.97 Million INR | 292.01% |
| Themis Medicare Limited | 764.96 Million INR | 136.39% |
| Unichem Laboratories Limited | 931.91 Million INR | 129.871% |
| Vaishali Pharma Limited | 119.13 Million INR | 333.658% |
| Venus Remedies Limited | -267.7 Million INR | -3.985% |
| Wanbury Limited | 1.1 Billion INR | 125.172% |
| Windlas Biotech Limited | -273.04 Million INR | -1.952% |
| ZIM Laboratories Limited | 983.6 Million INR | 128.301% |
| Ipca Laboratories Limited | 11.41 Billion INR | 102.439% |
| Aarti Drugs Limited | 5.54 Billion INR | 105.017% |
| Aarti Pharmalabs Limited | 2.61 Billion INR | 110.658% |
| Biofil Chemicals and Pharmaceuticals Limited | -18.44 Million INR | -1409.102% |
| Brooks Laboratories Limited | 49.48 Million INR | 662.532% |
| Eris Lifesciences Limited | 13.8 Billion INR | 102.016% |
| IOL Chemicals and Pharmaceuticals Limited | -1.1 Billion INR | 74.724% |
| Sigachi Industries Limited | 859.94 Million INR | 132.37% |
| Sakar Healthcare Limited | 790.93 Million INR | 135.195% |
| Aurobindo Pharma Limited | 3.69 Billion INR | 107.537% |
| Divi's Laboratories Limited | -39.77 Billion INR | 99.3% |
| AstraZeneca Pharma India Limited | -5.01 Billion INR | 94.446% |
| Mankind Pharma Limited | -1.74 Billion INR | 84.078% |
| Sequent Scientific Limited | 4.17 Billion INR | 106.662% |
| Neuland Laboratories Limited | -214.05 Million INR | -30.044% |
| J. B. Chemicals & Pharmaceuticals Limited | 2.82 Billion INR | 109.867% |
| Glenmark Pharmaceuticals Limited | -4.28 Billion INR | 93.504% |
| Zydus Lifesciences Limited | 3.91 Billion INR | 107.116% |
| Amrutanjan Health Care Limited | -248.79 Million INR | -11.888% |
| Wockhardt Limited | 18.27 Billion INR | 101.524% |
| Bal Pharma Limited | 1.26 Billion INR | 122.031% |
| Dr. Reddy's Laboratories Limited | 12.91 Billion INR | 102.156% |
| Bliss GVS Pharma Limited | -1.15 Billion INR | 75.956% |
| Par Drugs and Chemicals Limited | -366.53 Million INR | 24.055% |
| Caplin Point Laboratories Limited | -5.5 Billion INR | 94.946% |
| Shilpa Medicare Limited | 9.06 Billion INR | 103.069% |
| Valiant Laboratories Limited | 649.9 Million INR | 142.832% |
| Ajanta Pharma Limited | -954.9 Million INR | 70.848% |
| Aarey Drugs & Pharmaceuticals Limited | 297.57 Million INR | 193.544% |
| Granules India Limited | 9.28 Billion INR | 102.997% |
| Medicamen Biotech Limited | 160.31 Million INR | 273.638% |
| Syncom Formulations (India) Limited | 46.21 Million INR | 702.387% |
| Piramal Enterprises Limited | 491.39 Billion INR | 100.057% |
| Torrent Pharmaceuticals Limited | 31.83 Billion INR | 100.875% |
| NATCO Pharma Limited | -5.81 Billion INR | 95.215% |
| Suven Life Sciences Limited | -1.63 Billion INR | 82.95% |
| Krebs Biochemicals & Industries Limited | 1.93 Billion INR | 114.401% |
| Strides Pharma Science Limited | 23.25 Billion INR | 101.197% |
| Indoco Remedies Limited | 6.47 Billion INR | 104.298% |
| Alpa Laboratories Limited | 35.36 Million INR | 887.176% |
| Lasa Supergenerics Limited | 205.79 Million INR | 235.263% |
| Sun Pharma Advanced Research Company Limited | -941.8 Million INR | 70.443% |